WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance ...
Teleflex Incorporated announced the FDA 510(k) clearance for an expansion of the QuikClot Control+™ Hemostatic Device's indications, now including all grades of internal and external bleeding.
Hosted on MSN
Teleflex Announces FDA Clearance for Expanded Use of QuikClot Control+ Hemostatic Device
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of its QuikClot Control+™ Hemostatic ...
WAYNE, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results